Quad Cities Investment Group, LLC Gilead Sciences, Inc. Transaction History

Quad Cities Investment Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $31,919 - $35,110	-518 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $4,313 - $4,761	69 Added 15.37%	518 $328,000
Q2 2019 Jul 17, 2019	BUY	$61.87 - $69.38 $309 - $346	5 Added 1.13%	449 $30,000
Q1 2019 Apr 09, 2019	SELL	$62.53 - $70.05 $18,508 - $20,734	-296 Reduced 40.0%	444 $29,000
Q4 2018 Feb 06, 2019	BUY	$60.54 - $79.0 $242 - $316	4 Added 0.54%	740 $47,000
Q3 2018 Oct 18, 2018	BUY	$71.28 - $78.92 $213 - $236	3 Added 0.41%	736 $57,000
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $47,557 - $55,473	733 New	733 $52,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Quad Cities Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Quad Cities Investment Group, LLC with notifications on news.